Suppr超能文献

体外膜肺氧合系统用于心源性休克的复苏。

Resuscitation for cardiogenic shock with extracorporeal membrane oxygenation systems.

作者信息

Phillips S J

机构信息

Iowa Heart Center, Mercy Hospital Medical Center, Des Moines, IA.

出版信息

Semin Thorac Cardiovasc Surg. 1994 Jul;6(3):131-5.

PMID:7948287
Abstract

Between 1975 and 1993, 73 patients in cardiogenic shock were supported by a variety of venoarterial pumping (VAP) systems. There were 64 adults and 9 children. Shock was caused by myocardial infarction (MI) (26), failed percutaneous transluminal coronary angioplasty (PTCA) (25), post open heart surgery (9), viral cardiomyopathy (5), idiopathic cardiomyopathy (2), pulmonary embolism (2), hypothermia (2), and arrhythmia (2). Forty-three patients were treated with percutaneous bypass and 30 by surgical bypass. Resuscitated patients were usually bridged to further therapies such as coronary artery bypass graft (CABG), valve repair or replacement or cardiac transplantation. Overall, 35 patients (48%) survived VAP and additional therapies. We conclude that early application of complete cardiopulmonary support to patients in shock allows resuscitation and corrective therapy with an acceptable salvage rate.

摘要

1975年至1993年间,73例心源性休克患者接受了各种静脉-动脉泵(VAP)系统的支持治疗。其中有64名成人和9名儿童。休克的病因包括心肌梗死(MI)(26例)、经皮腔内冠状动脉成形术(PTCA)失败(25例)、心脏直视手术后(9例)、病毒性心肌病(5例)、特发性心肌病(2例)、肺栓塞(2例)、体温过低(2例)和心律失常(2例)。43例患者接受了经皮旁路治疗,30例接受了手术旁路治疗。复苏后的患者通常会过渡到进一步的治疗,如冠状动脉旁路移植术(CABG)、瓣膜修复或置换或心脏移植。总体而言,35例患者(48%)在接受VAP及其他治疗后存活。我们得出结论,对休克患者早期应用完全心肺支持可实现复苏和纠正治疗,且挽救率可接受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验